Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01740895 · ClinicalTrials.gov registry record
ADenosine Vasodilator Independent Stenosis Evaluation II - ADVISE II
A clinical trial, sponsored by Volcano Corporation.
- Completed
- Registry status
- 818
- Enrollment target
NCT01740895 is a clinical trial that has completed, run by Volcano Corporation. The registered enrollment target is 818 participants.
The verdict
NCT01740895 has completed, sponsored by Volcano Corporation.
- COMPLETED
- Registry status
- 818 participants
- Enrollment target
Study Summary
To assess the clinical value of iFR to characterize, without concomitant administration of hyperemic agents and outside a specified range of iFR values, coronary stenosis severity as determined with fractional flow reserve (FFR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 818 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01740895
The ClinicalTrials.gov registry entry for NCT01740895 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 818 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Volcano Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01740895 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01740895 about?
NCT01740895 is a clinical study titled "ADenosine Vasodilator Independent Stenosis Evaluation II - ADVISE II". To assess the clinical value of iFR to characterize, without concomitant administration of hyperemic agents and outside a specified range of iFR values, coronary stenosis severity as determined with fractional flow reserve (FFR)
What is the current status of trial NCT01740895?
This trial is currently completed. The enrollment target is 818 participants. The study started on 2012-12. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT01740895?
This trial is sponsored by Volcano Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.